<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="118718">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01557465</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00032758</org_study_id>
    <nct_id>NCT01557465</nct_id>
  </id_info>
  <brief_title>Mechanical Alternans Study</brief_title>
  <acronym>MAS</acronym>
  <official_title>Study of Mechanical Alternans for Prediction of Ventricular Tachyarrhythmias</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether mechanical alternans (alternating strong
      and weak heart beats with a constant beat-to-beat interval), can be used to predict
      malignant ventricular arrhythmias, requiring defibrillation or appropriate ICD therapies,
      and to predict progression of heart failure and death.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>sudden arrhythmic death</measure>
    <time_frame>5 years</time_frame>
    <description>appropriate ICD therapy due to fast ventricular tachycardia or ventricular fibrillation, or sudden cardiac death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cardiovascular mortality</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>all-cause death</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>appropriate ICD therapies</measure>
    <time_frame>5 years</time_frame>
    <description>either ICD shock or antitachycardia pacing due to ventricular arrhythmia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>composite heart failure endpoint</measure>
    <time_frame>5 years</time_frame>
    <description>pump-failure death, or heart transplantation, or heart failure hospitalization, whichever came first</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">134</enrollment>
  <condition>Ischemic Cardiomyopathy</condition>
  <condition>Nonischemic Cardiomyopathy</condition>
  <condition>Heart Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with structural heart disease, ischemic or non-ischemic cardiomyopahty
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  structural heart disease

          -  ischemic or non-ischemic cardiomyopathy

        Exclusion Criteria:

          -  pregnancy

          -  age &lt; 18 years old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Johns Hopkins University School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Kim R, Cingolani O, Wittstein I, McLean R, Han L, Cheng K, Robinson E, Brinker J, Schulman SS, Berger RD, Henrikson CA, Tereshchenko LG. Mechanical alternans is associated with mortality in acute hospitalized heart failure: prospective mechanical alternans study (MAS). Circ Arrhythm Electrophysiol. 2014 Apr;7(2):259-66. doi: 10.1161/CIRCEP.113.000958. Epub 2014 Mar 1.</citation>
    <PMID>24585716</PMID>
  </results_reference>
  <verification_date>April 2015</verification_date>
  <lastchanged_date>April 6, 2015</lastchanged_date>
  <firstreceived_date>March 16, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>Larisa Tereshchenko</investigator_full_name>
    <investigator_title>Instructor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
